Abstract
The physiologic sequelae of Renal Artery Stenosis (RAS) results from narrowing of renal artery lumen which leads to diminished renal perfusion. The consequences of RAS range from asymptomatic to refractory hypertension to ischemic nephropathy eventually leading to end-stage renal disease (ESRD).
Keywords: Renal Artery Stenosis (RAS), hypertension, end-stage renal disease (ESRD), nephropathy, etiology
Current Hypertension Reviews
Title: Renal Artery Stenting: Efficacy and Complications
Volume: 5 Issue: 1
Author(s): Mohsen Bannazadeh and Timur Sarac
Affiliation:
Keywords: Renal Artery Stenosis (RAS), hypertension, end-stage renal disease (ESRD), nephropathy, etiology
Abstract: The physiologic sequelae of Renal Artery Stenosis (RAS) results from narrowing of renal artery lumen which leads to diminished renal perfusion. The consequences of RAS range from asymptomatic to refractory hypertension to ischemic nephropathy eventually leading to end-stage renal disease (ESRD).
Export Options
About this article
Cite this article as:
Bannazadeh Mohsen and Sarac Timur, Renal Artery Stenting: Efficacy and Complications, Current Hypertension Reviews 2009; 5 (1) . https://dx.doi.org/10.2174/157340209787314342
DOI https://dx.doi.org/10.2174/157340209787314342 |
Print ISSN 1573-4021 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6506 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Hypertension and Counter-Hypertension Mechanisms in Giraffes
Cardiovascular & Hematological Disorders-Drug Targets Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies
Current Drug Targets - Inflammation & Allergy Age-Related Changes and Effects of Mild Hypothermia on Carotid Artery Reactivity in Newborn Rats
CNS & Neurological Disorders - Drug Targets Angiogenesis Inhibitors: Implications for Combination with Conventional Therapies
Current Pharmaceutical Design Challenges in Diagnosing Cerebral Lacunar Infarcts
Current Medical Imaging Diet and Metabolic Syndrome: An Overview
Current Vascular Pharmacology Renal and Cardiac Effects of Renal Sympathetic Denervation and Carotid Baroreceptor Stimulation
Current Vascular Pharmacology Brain Inflammation Following Intracerebral Hemorrhage
Current Neuropharmacology Exosomes and Exosomal microRNAs in Age-associated Stroke
Current Vascular Pharmacology Ethanol Induced Oxidative Stress in the Vasculature: Friend or Foe
Current Hypertension Reviews Recent Patents on Ocular Drug Delivery Systems
Recent Patents on Drug Delivery & Formulation Editorial (Thematic Issue: “Pregnancy in Women with Metabolic Syndrome”)
Current Pharmaceutical Biotechnology Herbal Drugs for Diabetic Treatment: An Updated Review of Patents
Recent Patents on Anti-Infective Drug Discovery Inflammation Markers in Essential Hypertension
Medicinal Chemistry The Chemistry of Bioactive Diterpenes
Current Organic Chemistry New Oral Anticoagulants in Prophylaxis of Venous Thromboembolic Disease in Major Orthopedic Surgery
Cardiovascular & Hematological Disorders-Drug Targets Depression, Antidepressants and Hypertensive Disorders of Pregnancy: A Systematic Review
Current Drug Safety Differential ERK1/2 Signaling and Hypertrophic Response to Endothelin-1 in Cardiomyocytes from SHR and Wistar-Kyoto Rats: A Potential Target for Combination Therapy of Hypertension
Current Vascular Pharmacology Pharmacologic and Perioperative Considerations for Antihypertensive Medications
Current Clinical Pharmacology Effects of Evolocumab on Cardiovascular Events
Current Cardiology Reviews